Nanosonics Earnings Call Highlights Profitable Growth Path

Nanosonics Limited ((AU:NAN)) has held its Q2 earnings call. Read on for the main highlights of the call.

Nanosonics’ latest earnings call struck an upbeat tone, with management emphasizing solid top-line momentum, expanding operating margins and growing recurring revenues despite a few macro and FX headwinds. Executives framed the period as one of disciplined execution and strategic investment, particularly around CORIS, underpinned by a strong balance sheet and reaffirmed multi‑year guidance.

Revenue Growth

Nanosonics reported H1 FY26 revenue of $102.2 million, up 9% year over year, or 8% in constant currency, demonstrating steady demand across its portfolio. Both recurring and capital revenue streams contributed to the growth, giving investors confidence that the business is not reliant on a single engine.

Operating Margin Expansion

Operating margin rose 27% to $8.5 million for the half, as management kept operating expenses tightly controlled. OpEx increased just 4% to $69.5 million, highlighting clear operating leverage and reinforcing the earnings power of the underlying business.

Installed Base and Patient Reach

The installed base expanded to 38,080 devices, up 6% versus a year ago, continuing to deepen Nanosonics’ footprint in infection prevention. Management estimates this fleet now protects approximately 29 million patients annually, underscoring the scale and relevance of its technology in clinical settings.

Strong Installation and Upgrade Activity

Total installations climbed 20% to 2,070 devices during the half, with North America delivering a record level of upgrade activity. These upgrades are becoming a critical growth lever, boosting capital revenue today while seeding higher future consumables and software income.

Recurring Revenue Momentum

Recurring revenue increased 9% year over year, supported by broad‑based growth. Core consumables rose 9%, ecosystem consumables 6%, and service and repairs surged 24%, reflecting a maturing and more heavily used installed base that is increasingly sticky.

Trophon-Only Business Performance

The trophon‑only segment delivered operating margin of $25.6 million, up 20% on the prior period, with margin as a share of sales improving to 25% from 22.9%. EBIT grew 9%, reinforcing that this is a scalable, high‑margin core franchise capable of funding investment in new platforms.

Capital Revenue and Pricing Dynamics

Capital revenue reached $26.5 million in the half, up 9% year on year, largely driven by volume upgrade agreements with key customers. While these larger deals pulled down average selling prices in the short term, management highlighted that they significantly expand the recurring revenue and software upgrade base.

CORIS Regulatory and Commercial Progress

CORIS hit several milestones, including regulatory registrations in Australia, Europe and the U.K., as well as submission of its first U.S. 510(k) for expanded indications. The platform has entered a Controlled Market Release in the U.K., with a more meaningful commercial rollout expected region by region from FY27.

Strong Balance Sheet and Cash Position

The company remains debt‑free, closing the half with cash of $159.8 million, giving it ample firepower for growth initiatives. A modest cash outflow of about $1.4 million reflected CORIS inventory ramp‑up, investment spending and an ongoing share buyback program, with roughly $4 million of repurchases completed.

Operational and Digital Investments

Nanosonics advanced its product and infrastructure roadmap, launching the next‑generation trophon3 and trophon2 Plus software upgrade. It also implemented a new ERP platform, rolled out cloud‑based traceability solutions and secured a new headquarters with expanded manufacturing capacity to support future scale.

Gross Margin Moderation

Gross margin eased to 76.3%, roughly 2.2 percentage points lower than a year earlier, tempering some of the operating upside. Management cited U.S. tariffs, higher air freight costs and product mix shifts toward capital and upgrades as the main drivers of the margin compression.

Reported EBIT and PBT Declines (FX Impact)

Reported EBIT came in at $8.4 million, down 3% year on year, with profit before tax also slipping about 3%. These headline declines largely reflected currency swings, including a net unrealized FX loss of around $0.7 million and roughly a $2 million negative FX swing versus the prior period.

Spare Parts Revenue Decline

Spare parts revenue fell 23% year over year, which management linked to customer inventory dynamics and lower replacement needs. As clients upgrade to newer trophon systems, spare‑parts demand is naturally moderating, partially offset by higher service and repair revenues.

Average Selling Price Moderation

Higher‑volume upgrade agreements and a sales mix skewed toward trophon2 units in H1 weighed on average selling prices for capital equipment. Management cautioned that similar ASP pressure could persist into H2 depending on deal composition, though it views this as an accepted trade‑off for a larger recurring base.

FX Sensitivity to Guidance

Management reiterated that guidance remains sensitive to FX movements despite hedging. They noted that if the AUD/USD rate were to move to about 0.70 in H2, the revenue guidance range could be trimmed by roughly 3%, introducing a non‑operational risk factor for investors to monitor.

CORIS Investment and OpEx Increase

Operating expenses tied to CORIS increased around 16% as commercialization preparations accelerated, particularly around Controlled Market Releases. Management signaled that incremental resources will continue to be added ahead of meaningful revenue, implying a gradual uplift in OpEx as CORIS ramps toward FY27.

Near-Term Cash Outflow Drivers

The modest cash outflow of approximately $1.4 million in the half was driven by CORIS inventory buildup, ongoing platform investment and the share buyback. While near‑term cash usage is elevated, management stressed that the balance sheet can comfortably support these growth‑oriented outlays.

Forward-Looking Guidance and Outlook

Nanosonics reaffirmed its FY26 constant‑currency guidance for 8–12% revenue growth, supported by continued capital unit expansion and recurring revenue gains. The company expects gross margins of 75–77%, ongoing OpEx discipline and further operating margin expansion, while noting tariff, FX and CORIS ramp costs as key variables.

Nanosonics’ earnings call painted a picture of a company balancing profitable core growth with disciplined, but meaningful, investment in its next technology wave. With a robust trophon franchise, a cash‑rich balance sheet and clear timelines for CORIS commercialization, investors are being asked to accept near‑term margin and cash noise in exchange for longer‑term scale and diversification.